Keymed Biosciences Announces 2022 Annual Results: Efficiently Promotes Clinical Progress & Proactively Develops Global Strategic Collaboration
/PRNewswire/ -- Keymed Biosciences Inc. (HKEX: 02162) announced its 2022 annual results. Focused on unmet clinical needs, the Company continued to efficiently...
United States Hong Kong Keymed Bio Biosciences Inc Keymed Biosciences Inc Team Of Talents Expanded Manufacturing Capabilities
Source: prnewswire.com